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Background. Strategies combining pretest clinical assessment and D-dimers measurement eﬃciently and safely rule out venous
thromboembolism events (VTE) in low- and intermediate-risk patients. Objectives. As process of ageing is associated with altered
concentrations of coagulation markers including an increase in D-dimers levels, we investigated whether D-dimers could reliably
ruleoutVTEacrossagecategories.Method.Weprospectivelyassessedthetestperformancein1,004patientsvisitingtheemergency
department during the 6-month period with low or intermediate risk of VTE who also received additional diagnostic procedures.
Results. 67 patients had VTE with D-dimers levels above the threshold, and 3 patients displayed D-dimers levels below the
threshold. We observed that speciﬁcity of D-dimers test decreased in an age-dependent manner. However, sensitivity and negative
predictive value remained at very high level in each age category including older patients. Conclusion.W ec o n c l u d et h a t ,e v e n
though D-dimers level could provide numerous false positive results in elderly patients, its high sensitivity could reliably help
physicians to exclude the diagnosis of VTE in every low- and intermediate-risk patient.
1.Introduction
Venous thromboembolism events (VTE) are common disor-
ders with major impact on clinical and economic outcomes
[1].Asaresult,diagnosticprocedureshavebeendevelopedto
safely rule out the occurrence of VTE especially in the setting
of emergency medicine. Several studies have underlined
that D-dimers level below 500ng/ml reliably excluded the
diagnosis of VTE in patients previously identiﬁed by clinical
pretest evaluation as low- or intermediate-risk patients [2–
7]. The use of combined strategies including both clinical
assessment and D-dimers measurement have been endorsed
by most professional societies as they improve diagnosis with
acceptable cost eﬃciency. As frequency of VTE increases
with age, diagnostic strategies should be adjusted to elderly
age groups of patients. However, interpretation of D-dimers
level is altered in older patients, as ageing or underlying
clinical conditions may activate coagulation. Consequently,
performance of diagnostic strategies using D-dimers varies
withage.Inguidelinesreleasedin2000,theEuropeanSociety
of Cardiology recommended the avoidance of D-dimers
measurement in patients older than 80 years of age [8].
We therefore assessed the clinical value of D-dimers test
across age categories in patients presenting in the emergency
department with low- or intermediate-risk of VTE.
2.MaterialsandMethods
We conducted a prospective, observational, and single
centred study in the emergency department of a tertiary-
level teaching hospital during the 6-month period. Study
protocol and procedures complied with the principles of the
Declaration of Helsinki. The institutional review board for
the protection of human subjects in our hospital approved
the study protocol and patients information procedures
(study notiﬁcation letter).
We enrolled all consecutive consenting adults (18 years
old or above) who required D-dimers blood test for the diag-
nostic purposes of venous thromboembolism events (VTE),
that is, deep venous thrombosis (DVT) and pulmonary
embolism (PE). Diagnostic probability of VTE was based on
the Wells score dedicated to DVT or PE, as required [3–6].2 Emergency Medicine International
Patients were excluded if they refused to participate in
the study, if they were less than 18 years of age, if they were
pregnant, if they were perceived as a high risk for VTE after
calculationoftheWellsscore,oriftheywerelosttofollow-up
at the end of the study period.
Patients’ management was based on currently recom-
mended practice guidelines. Brieﬂy, physicians were edu-
cated on diagnostic procedures for DVT and PE including
the Wells pretest clinical scoring system, and computerized
procedures were available at the bedside. According to Wells
scores, D-dimers blood levels were required for the patients
indicating low or intermediate probability for VTE. The
attending physician made the score-based decision and pro-
ceeded to baseline data collection through patient interviews
and standardized review of medical records. Baseline data
consisted of demographic data (age, gender), coexisting
illnesses, symptoms, and Wells score calculation for VTE
probability. Patients were stratiﬁed by their age in the fol-
lowing eight age cohorts: <30 years of age (years), 31–39, 40–
49, 50–59, 60–69, 70–79, 80–89, and >90 years. Pulmonary
angiography on a multislice computerised tomography (CT)
scan and lower limb compression ultrasonography were
guidedbyprocedures.PatientswereclassiﬁedasVTEornon-
VTE after the diagnostic procedures, if required, and at the
e n do fa3 - m o n t hf o l l o w u p .
D-dimers were measured using the ELISA quick test
VIDAS. Patients were positive for D-dimers if the level was
>500ng/ml; otherwise, patients were considered negative for
D-dimers.
Our objective was to assess the overall eﬀectiveness
of D-dimers levels to detect VTE across age categories in
patients with low and intermediate risk of VTE. A value of
P<. 05 was considered statistically signiﬁcant. Comparisons
between patients with or without VTE were made by the
χ2 test for categorical variables and the Mann Whitney
test for continuous variables. All variables were analyzed
based on their association with the presence of a thrombosis
(>500ng/ml) having or not a VTE, using Fisher’s exact test.
Sensitivity, speciﬁcity, negative predictive value of D-dimers,
and their 95% conﬁdence interval (95%CI) were calculated
for each age class.
All tests were two-sided, and P-values below .05 were
considered statistically signiﬁcant. All statistical analyses
were performed using SAS software V9.1 (SAS institute,
Cary, NC).
3. Results
During the study period, 1,042 patients were enrolled; 38
could not be evaluated for the primary end point and 1,004
could be evaluated at 3 months for both D-dimers level and
the presence of PE or DVT. Among these, 539 were negative
for D-dimers and 465 were positive. Mean age was 74 years
(19–99years)forpatientspositiveforD-dimers,and48years
(18–93 years) for patients negative for D-dimers (P<,001).
Only 12% of patients aged 70 or above had negative D-
dimers. In the group of patients positive for D-dimers, 67
(14%) had a diagnosis of either DVT (n = 15, 3%) or PE
(n = 52, 11%). In patients with negative D-dimers, 3 were
identiﬁed with VTE at the end of the followup (one patient
with DVT, two with PE). We observed that incidence of VTE
roughly increased with age, corresponding to 5% or less in
the younger patients, and reaching 13% in 80 to 89 age
cohort.
Overall sensitivity and speciﬁcity of D-dimers were
95,7% [95% CI: 0,880–0,991] and 57,4% [95% CI: 0.542–
0.605], respectively. Negative and positive predictive values
were0,994[95%CI:0,984–0,999]and0,144[95%CI:0.114–
0.179]. The performance of D-dimers across age categories
underscoredthatspeciﬁcitywaselevatedinyoungerpatients,
and dramatically decreased in elderly especially in those who
were 80 years or older. Conversely, sensitivity of the test
remained above 80%, and the negative predictive value of D-
dimers was maintained across age cohorts (Table 1).
4. Discussion
Coagulation is a tightly ampliﬁed and regulated process.
It generates an intricately related network that contributes
to the adequate response against the primary insult [9].
During the ageing, these mechanisms are deregulated.
More precisely, with ageing, there is an imbalance in the
coagulation cascade that navigates towards a prothrombotic
environment.Thisissupportedbyourstudythatreportedan
increasingnumberofVTEwithageing,withapredominance
of PE.
Severalstudiesreportedpronouncedactivationofcoagu-
lation system in older patients characterized by higher levels
of ﬁbrinogen, factors VII, VIII, IX, and other clotting factors
[10, 11]. The analysis of a large cohort from the North
American Cardiovascular Health Study pointed out the
association between clotting and inﬂammatory markers and
frailty in elderly population even in the absence of clinically
relevant comorbidity [12]. In 1995, Mari et al. reported
that baseline coagulation activity physiologically increased
in centenarians with increased thrombin concentration and
elevated level of D-dimers [10]. These data predicted the
weak signiﬁcance of D-dimers elevation in older patients.
Few elderly patients were included in the studies report-
ing procedures to rule out VTE using a decision making
process based upon D-dimers threshold. In 2001, Wells et
al. published the strategy for diagnosis of PE in patients
whose mean age was 50.5 years (18.4), ranging from 16 to
93 years [4]. Two years later, the same authors published
an approaching strategy in patients with suspected DVT
whose mean age was 58 years [3]. These cornerstone studies
did not speciﬁcally assess the relevance of these strategies
in older patients. Rathbun et al., in 2004, evaluated such
procedures in patients that were from 19 to 83 years [7].
One prospective and three retrospective studies previously
assessed the performance of D-dimers in elderly patients
visiting the emergency department with suspected PE [13–
17]. These studies used various methods for D-dimers mea-
surement. Sensitivity was almost 100% [14, 15]a c r o s sa l la g e
groups, and the negative predictive value remained clinically
relevant in elderly, ranging from 82.4% to 100%. However,
speciﬁcity decreased below 50% after 70 years, dropping to
14.3% in the very old patients. This suggested that D-dimersEmergency Medicine International 3
Table 1: Performance of the D-dimers “Vidas” assay according to age categories in 1,004 patients with suspected venous thromboembolic
events (VTE). 95%CI: 95% conﬁdence interval.
Age categories (years) No. of patients No. of VTE Sensitivity [95%CI] Speciﬁcity [95%CI] Negative predictive value [95%CI]
<30 91 5 80% [28.4–99.5] 83.5% [74.3–90.5] 98.7% [93.0–100]
30–39 121 5 80% [28.4–99.5] 75.6% [67.0–83.0] 98.9% [94.0–100]
40–49 151 7 100% [59.0–100] 78.7% [71.3–84.9] 100% [96.9–100]
50–59 155 6 83.3% [35.9–99.6] 69.2% [61.4–76.4] 99.1% [95.0–100]
60–69 142 11 100% [71.5–100] 56% [47.1–64.5] 100% [95.2–100]
70–79 165 14 100% [76.8–100] 33.3% [26.1–41.1] 100% [93.4–100]
80–89 134 18 100% [81.5–100] 10.1% [5.3–17.0] 100% [73.5–100]
>90 45 4 100% [39.8–100] 7.3% [4.0–20.0] 100% [29.2–100]
All patients 1,004 70 95.8% [88.0–99.0] 57.4% [54.2–60.5] 99.4% [98.4–99.9]
should be used cautiously to rule out, diagnosis of VTE in
elderly population. Additionally, increasing D-dimers cutoﬀ
resultedin anunacceptablelossof sensitivity witha marginal
increase of speciﬁcity [11, 13, 17].
In this paper, we have demonstrated that negative pre-
dictive value of D-dimers measurement using the reference
method eﬃciently ruled out the diagnosis of VTE in low-
or intermediate-risk patients across age categories whereas
speciﬁcity decreased in an age-dependent manner. The
overall sensitivity of D-dimers was relatively low—95,7%
[95%CI 0.880–0.991]—as compared to previous studies
whose sensitivity was nearly 100%. Conversely, we observed
a high overall speciﬁcity of D-dimers that dramatically
dropped in the older patients, as previously reported. A
former study reported decreased sensitivity (22% to 14%)
and speciﬁcity (31% to 22%) in patients older than 75 years
[16]. Similar results were observed in patients older than 70
years [13, 14]. In our paper, the number of patients with D-
dimers level above the threshold increased with age, and only
3% of patients above 90 years had negative D-dimers.
Since speciﬁcity of D-dimers was poor in patients
older than 80, the European Society of Cardiology [8]
recommended that D-dimers are not to be used in the
latter population no matter what pretest risk category for
VTE is. However, negative D-dimers still rule out VTE
in older patients. As PE occurs most frequently and since
ultrasounds are of a minor help in this condition, our results
as well as other results point out the applicability of the
rule-out strategies for PE in the frailest elderly population.
Rule-out strategies could spare the elderly patients from
potentially detrimental investigations requiring intravenous
radiocontrast [18].
This study has several limitations. We conducted a single
centre study; patients were excluded if they were perceived
as a high risk for VTE after calculation of the Wells score;
the number of consecutive patients enrolled in this study was
not evaluated ap r i o r i ; in addition, the number of patients is
heterogeneous across the age cohorts and some age cohorts,
are probably underrepresented.
5. Conclusion
In conclusion, we recommend the use of D-dimer testing in
elderly patients to rule out pulmonary embolism in low- and
intermediate-risk patients where its negative predictive value
and sensitivity remain 100%.
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